Patents Assigned to CryoHeart Laboratories, Inc.
  • Publication number: 20220192832
    Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.
    Type: Application
    Filed: March 11, 2022
    Publication date: June 23, 2022
    Applicant: CryoHeart Laboratories, Inc.
    Inventors: Frederick J. Thabet, Ravi Kanagala, James Searle
  • Patent number: 11253366
    Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: February 22, 2022
    Assignee: CryoHeart Laboratories, Inc.
    Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
  • Patent number: 11197760
    Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes an inner layer and an outer layer. The outer layer at least partially surrounds the inner layer and is operable to abut against the two sections of the bone. The outer layer is porous and/or fibrous and is operable to receive at least one cellular growth factor.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: December 14, 2021
    Assignee: Cryoheart Laboratories, Inc.
    Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
  • Publication number: 20210220141
    Abstract: A synthetic implant is provided that is operable to be disposed between and fuse two sections of a bone. The synthetic implant includes a synthetic material that is operable to abut against the two sections of the bone. The synthetic material is porous and/or fibrous and is operable to receive at least one cellular growth factor. The synthetic material can be combined with other synthetic materials or human bone tissue or animal bone tissue or other human or animal tissue that is suitable to act as a platform or scaffold on which new bone can grow or to cause bone to fuse together.
    Type: Application
    Filed: April 6, 2021
    Publication date: July 22, 2021
    Applicant: CryoHeart Laboratories, Inc.
    Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
  • Publication number: 20200060829
    Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes a material that is operable to abut against the two sections of the bone. The material is porous and/or fibrous and is operable to receive at least one cellular growth factor.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 27, 2020
    Applicant: CryoHeart Laboratories, Inc.
    Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle
  • Publication number: 20200022814
    Abstract: An implant is provided that is operable to be disposed between and fuse two sections of a bone. The implant includes an inner layer and an outer layer. The outer layer at least partially surrounds the inner layer and is operable to abut against the two sections of the bone. The outer layer is porous and/or fibrous and is operable to receive at least one cellular growth factor.
    Type: Application
    Filed: July 19, 2019
    Publication date: January 23, 2020
    Applicant: CryoHeart Laboratories, Inc.
    Inventors: Frederick J. Thabet, II, Ravi Kanagala, James Searle